Strait of Hormuz blockade persists, but India’s imports of Russian oil are down from highs seen in March – here’s why

Nearly all Indian refiners, except Numaligarh Refinery, are now importing Russian crude. (AI image) India’s imports of crude oil from Russia have dropped from the highs seen in March when the supply disruptions from the Middle East caused by the US-Iran war and the Strait of Hormuz closure prompted refiners to step up buys from…

Read More

Rs 4,000 crore infra push: PM Modi unveils key projects in Sikkim across healthcare, housing, education and other sectors

Prime Minister Narendra Modi is on a two-day visit to Sikkim, where he is participating in the State’s Golden Jubilee celebrations of statehood. During the event, the Prime Minister described the Northeast as India’s “Ashtalakshmi” and highlighted the Himalayan State’s significance within it. During the visit, he also inaugurated and laid the foundation stone of…

Read More

RIL, Axis Bank & more: Top stocks to watch on April 28, 2026

Goldman Sachs maintained its buy rating on Reliance Industries with the target price at Rs 1,910. Analysts said the company reported Jan-March (Q4FY26) earnings before interest, taxes, depreciation and amortisation (EBITDA) miss due to weak oil-to-consumer (O2C) margin capture, while high crude premiums and logistics costs offset strong product cracks. Analysts expected sequential margin recovery…

Read More

Banks to report all related party forex derivative transactions: RBI

Mumbai: RBI has required banks to report all foreign exchange derivative deals involving the rupee undertaken in India and globally by their entire group, including overseas branches, subsidiaries, and parent entities. This brings into view offshore trades that were earlier largely invisible. This applies to both OTC deliverable and offshore non-deliverable contracts, meaning even speculative…

Read More

In IPO boost, NSE shareholders to divest over 4%

Mumbai: The initial public offer for NSE, the largest stock exchange in India by trading turnover and revenue, got a boost on Monday as the required number of the bourse’s shareholders agreed to part with their holdings for the offer for sale (OFS) to move forward.Monday was the last day for NSE’s existing shareholders to…

Read More

Sun Pharma buys US-based Organon in $12bn all-cash deal

Mumbai, Apr 27 (ANI): Chairman of Sun Pharma Management Dilip Shanghvi speaks during a press conference at Worli, in Mumbai on Monday. (ANI Photo) New Delhi: In its boldest move yet, Sun Pharma, India’s largest pharma company, has struck the biggest-ever overseas pharma deal, acquiring US-listed Organon & Co for $11.8 billion (Rs 98,000 crore)…

Read More